|
|
 Previous Article | Table of Contents | Next Article 
Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA
Mario Cazzola,
Gaetano Bergamaschi,
Laura Tonon,
Eloisa Arbustini,
Maurizia Grasso,
Elena Vercesi,
Giovanni Barosi,
Paolo Emilio Bianchi,
Gaetano Cairo, and
Paolo Arosio
From the Department of Internal Medicine and Medical Oncology, Department of Human Pathology, Laboratory of Medical Informatics, and Department of Ophthalmology, University of Pavia Medical School and IRCCS Policlinico S. Matteo, Pavia; Institute of Pathology, University of Milan, Milan; and DIBIT, IRCCS Ospedale S. Raffaele, Milan, Italy.
Recent reports have described families in whom a combination of elevated serum ferritin not related to iron overload and congenital nuclear cataract is transmitted as an autosomal dominant trait. We have studied the molecular pathogenesis of hyperferritinemia in two families showing different phenotypic expression of this new genetic disorder. Serum ferritin levels ranged from 950 to 1,890 µg/L in affected individuals from family 1, and from 366 to 635 µg/L in those from family 2. Cataract was clinically manifested in family 1 and asymptomatic in family 2. By using monoclonal antibodies specific for the H and L ferritin subunits, serum ferritin was found to be essentially L type in both normal and affected individuals. The latter also showed normal amounts of H-type ferritin in circulating mononuclear cells; on the contrary, L-type ferritin contents were 13 times normal in family 1 and five times normal in family 2 on average. Serum ferritin was glycosylated in both normal and affected individuals. There was a close relationship between mononuclear cell L-type ferritin content and serum ferritin concentration (r = 0.95, P < .00001), suggesting that the excess production of ferritin in cells was directly responsible for the hyperferritinemia. The dysregulated L-subunit synthesis was found to result from different point mutations in a noncoding sequence of genomic L-subunit DNA, which behaves as an mRNA cis-acting element known as iron regulatory element (IRE). Affected individuals from family 1 were heterozygous for a point mutation (a single G to A change) in the highly conserved, three-nucleotide motif forming the IRE bulge. Affected members from family 2 were heterozygous for a double point mutation in the IRE lower stem. Using a gel retardation assay, the observed molecular lesions were shown to variably reduce the IRE affinity for an iron regulatory protein (IRP), which inhibits ferritin mRNA translation. The direct relationship between the degree of hyperferritinemia and severity of cataract suggests that this latter is the consequence of excessive ferritin production within the lens fibers. These findings provide strong evidence that serum ferritin is a byproduct of intracellular ferritin synthesis and that the L-subunit gene on chromosome 19 is the source of glycosylated serum ferritin. From a practical standpoint, this new genetic disorder should be taken into account by clinicians when facing a high serum ferritin in an apparently healthy person.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 814-821
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Cunat, M. Giansily-Blaizot, M. Bismuth, F. Blanc, O. Dereure, D. Larrey, A. L. Quellec, P. Pouderoux, C. Rose, I. Raingeard, et al.
Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders
Clin. Chem.,
December 1, 2007;
53(12):
2060 - 2069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Bateman, L. Richter, P. Flodman, D. Burch, S. Brown, P. Penrose, O. Paul, D. D. Geyer, D. G. Brooks, and M. A. Spence
A new locus for autosomal dominant cataract on chromosome 19: linkage analyses and screening of candidate genes.
Invest. Ophthalmol. Vis. Sci.,
August 1, 2006;
47(8):
3441 - 3449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ghosh, S. Hevi, and S. L. Chuck
Regulated secretion of glycosylated human ferritin from hepatocytes
Blood,
March 15, 2004;
103(6):
2369 - 2376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Craig, J. B. Clark, J. L. McLeod, M. A. Kirkland, G. Grant, J. E. Elder, M. G. Toohey, L. Kowal, H. F. Savoia, C. Chen, et al.
Hereditary Hyperferritinemia-Cataract Syndrome: Prevalence, Lens Morphology, Spectrum of Mutations, and Clinical Presentations
Arch Ophthalmol,
December 1, 2003;
121(12):
1753 - 1761.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Hetet, I. Devaux, N. Soufir, B. Grandchamp, and C. Beaumont
Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations
Blood,
September 1, 2003;
102(5):
1904 - 1910.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. Vallejo, H. Yang, P. A. Klimiuk, C. M. Weyand, and J. J. Goronzy
Synoviocyte-Mediated Expansion of Inflammatory T Cells in Rheumatoid Synovitis Is Dependent on CD47-Thrombospondin 1 Interaction
J. Immunol.,
August 15, 2003;
171(4):
1732 - 1740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Torti and S. V. Torti
Regulation of ferritin genes and protein
Blood,
May 15, 2002;
99(10):
3505 - 3516.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cremonesi, A. Fumagalli, N. Soriani, M. Ferrari, S. Levi, S. Belloli, G. Ruggeri, and P. Arosio
Double-Gradient Denaturing Gradient Gel Electrophoresis Assay for Identification of L-Ferritin Iron-responsive Element Mutations Responsible for Hereditary Hyperferritinemia-Cataract Syndrome: Identification of the New Mutation C14G
Clin. Chem.,
March 1, 2001;
47(3):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D Mumford, I. A Cree, J. D Arnold, M. C Hagan, K. C Rixon, and J. J Harding
The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin
Br J Ophthalmol,
July 1, 2000;
84(7):
697 - 700.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Cazzola and R. C. Skoda
Translational pathophysiology: a novel molecular mechanism of human disease
Blood,
June 1, 2000;
95(11):
3280 - 3288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Allerson, M. Cazzola, and T. A. Rouault
Clinical Severity and Thermodynamic Effects of Iron-responsive Element Mutations in Hereditary Hyperferritinemia-Cataract Syndrome
J. Biol. Chem.,
September 10, 1999;
274(37):
26439 - 26447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Balas, M. J. Aviles, F. Garcia-Sanchez, J. L. Vicario, and A. Cervera
Description of a New Mutation in the L-Ferritin Iron-Responsive Element Associated With Hereditary Hyperferritinemia-Cataract Syndrome in a Spanish Family
Blood,
June 1, 1999;
93(11):
4020 - 4021.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Levi, D. Girelli, F. Perrone, M. Pasti, C. Beaumont, R. Corrocher, A. Albertini, and P. Arosio
Analysis of Ferritins in Lymphoblastoid Cell Lines and in the Lens of Subjects With Hereditary Hyperferritinemia-Cataract Syndrome
Blood,
June 1, 1998;
91(11):
4180 - 4187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.D. Mumford, T. Vulliamy, J. Lindsay, and A. Watson
Hereditary Hyperferritinemia-Cataract Syndrome: Two Novel Mutations in the L-Ferritin Iron-Responsive Element
Blood,
January 1, 1998;
91(1):
367 - 368.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cozzi, B. Corsi, S. Levi, P. Santambrogio, A. Albertini, and P. Arosio
Overexpression of Wild Type and Mutated Human Ferritin H-chain in HeLa Cells. IN VIVO ROLE OF FERRITIN FERROXIDASE ACTIVITY
J. Biol. Chem.,
August 11, 2000;
275(33):
25122 - 25129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
